Division of Allergy and Clinical Immunology, The Johns Hopkins Asthma and Allergy Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
PLoS One. 2010 Nov 30;5(11):e14174. doi: 10.1371/journal.pone.0014174.
Th2-dominated inflammatory response in the airway is an integral component in the pathogenesis of allergic asthma. Accumulating evidence supports the notion that the phosphoinositide 3-kinase (PI3K) pathway is involved in the process. We previously reported that SHIP-1, a negative regulator of the PI3K pathway, is essential in maintaining lung immunohomeostasis, potentially through regulation of innate immune cells. However, the function of SHIP-1 in adaptive immune response in the lung has not been defined. We sought to determine the role of SHIP-1 in adaptive immunity in response to aeroallergen stimulation in the airway.
METHODOLOGY/PRINCIPAL FINDINGS: SHIP-1 knockout (SHIP-1-/-) mice on BALB/c background were immunized with ovalbumin (OVA) plus aluminum hydroxide, a strong Th2-inducing immunization, and challenged with OVA. Airway and lung inflammation, immunoglobulin response, Th2 cytokine production and lymphocyte response were analyzed and compared with wild type mice. Even though there was mild spontaneous inflammation in the lung at baseline, SHIP-1-/- mice showed altered responses, including less cell infiltration around the airways but more in the parenchyma, less mucus production, decreased Th2 cytokine production, and diminished serum OVA-specific IgE, IgG1, but not IgG2a. Naïve and OVA sensitized SHIP-1-/- T cells produced a lower amount of IL-4. In vitro differentiated SHIP-1-/- Th2 cells produced less IL-4 compared to wild type Th2 cells upon T cell receptor stimulation.
CONCLUSIONS/SIGNIFICANCE: These findings indicate that, in contrast to its role as a negative regulator in the innate immune cells, SHIP-1 acts as a positive regulator in Th2 cells in the adaptive immune response to aeroallergen. Thus any potential manipulation of SHIP-1 activity should be adjusted according to the specific immune response.
气道中的 Th2 主导的炎症反应是过敏性哮喘发病机制的一个组成部分。越来越多的证据支持这样一种观点,即磷酸肌醇 3-激酶(PI3K)途径参与这一过程。我们之前的报告表明,SHIP-1 是 PI3K 途径的负调节剂,对于维持肺免疫稳态至关重要,这可能是通过调节先天免疫细胞来实现的。然而,SHIP-1 在肺部适应性免疫反应中的功能尚未确定。我们试图确定 SHIP-1 在气道内对变应原刺激的适应性免疫反应中的作用。
方法/主要发现:在 BALB/c 背景下,SHIP-1 基因敲除(SHIP-1-/-)小鼠用卵清蛋白(OVA)加氢氧化铝免疫,这是一种强烈的 Th2 诱导免疫,并用 OVA 进行攻毒。分析并比较了气道和肺炎症、免疫球蛋白反应、Th2 细胞因子产生和淋巴细胞反应与野生型小鼠的差异。尽管在基线时有轻度的自发性肺部炎症,但 SHIP-1-/-小鼠表现出改变的反应,包括气道周围的细胞浸润减少但实质中的细胞浸润增多、粘液生成减少、Th2 细胞因子产生减少以及血清 OVA 特异性 IgE、IgG1 减少但 IgG2a 不变。幼稚和 OVA 致敏的 SHIP-1-/-T 细胞产生的 IL-4 量较少。与野生型 Th2 细胞相比,经 T 细胞受体刺激后,体外分化的 SHIP-1-/-Th2 细胞产生的 IL-4 较少。
结论/意义:这些发现表明,与作为先天免疫细胞中的负调节剂的作用相反,SHIP-1 在对变应原的适应性免疫反应中作为 Th2 细胞的正调节剂发挥作用。因此,任何对 SHIP-1 活性的潜在操作都应根据特定的免疫反应进行调整。